Novel Oral Anticoagulants (NOACs) vs. Warfarin in the Treatment of Cerebral venous Sinus Thrombosis (CVST): A retrospective study of functional and radiographic outcomes among patients enrolled in BEAST (Biorepository to Establish the Aetiology of Sinovenous Thrombosis) at UVA
Publication
, Conference
Wells, J; Ehrlich, M; Johansen, M; Rahman, S; Chapman, S; Worrall, B; Chiota-McCollum, N
Published in: NEUROLOGY
April 9, 2019
Duke Scholars
Published In
NEUROLOGY
EISSN
1526-632X
ISSN
0028-3878
Publication Date
April 9, 2019
Volume
92
Issue
15
Location
Philadelphia, PA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
71st Annual Meeting of the American-Academy-of-Neurology (AAN)
Related Subject Headings
- Neurology & Neurosurgery
- 3209 Neurosciences
- 3202 Clinical sciences
- 1702 Cognitive Sciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Wells, J., Ehrlich, M., Johansen, M., Rahman, S., Chapman, S., Worrall, B., & Chiota-McCollum, N. (2019). Novel Oral Anticoagulants (NOACs) vs. Warfarin in the Treatment of Cerebral venous Sinus Thrombosis (CVST): A retrospective study of functional and radiographic outcomes among patients enrolled in BEAST (Biorepository to Establish the Aetiology of Sinovenous Thrombosis) at UVA. In NEUROLOGY (Vol. 92). Philadelphia, PA: LIPPINCOTT WILLIAMS & WILKINS.
Wells, Jeremy, Matthew Ehrlich, Michelle Johansen, Shareena Rahman, Sherita Chapman, Bradford Worrall, and Nicole Chiota-McCollum. “Novel Oral Anticoagulants (NOACs) vs. Warfarin in the Treatment of Cerebral venous Sinus Thrombosis (CVST): A retrospective study of functional and radiographic outcomes among patients enrolled in BEAST (Biorepository to Establish the Aetiology of Sinovenous Thrombosis) at UVA.” In NEUROLOGY, Vol. 92. LIPPINCOTT WILLIAMS & WILKINS, 2019.
Wells J, Ehrlich M, Johansen M, Rahman S, Chapman S, Worrall B, et al. Novel Oral Anticoagulants (NOACs) vs. Warfarin in the Treatment of Cerebral venous Sinus Thrombosis (CVST): A retrospective study of functional and radiographic outcomes among patients enrolled in BEAST (Biorepository to Establish the Aetiology of Sinovenous Thrombosis) at UVA. In: NEUROLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2019.
Wells, Jeremy, et al. “Novel Oral Anticoagulants (NOACs) vs. Warfarin in the Treatment of Cerebral venous Sinus Thrombosis (CVST): A retrospective study of functional and radiographic outcomes among patients enrolled in BEAST (Biorepository to Establish the Aetiology of Sinovenous Thrombosis) at UVA.” NEUROLOGY, vol. 92, no. 15, LIPPINCOTT WILLIAMS & WILKINS, 2019.
Wells J, Ehrlich M, Johansen M, Rahman S, Chapman S, Worrall B, Chiota-McCollum N. Novel Oral Anticoagulants (NOACs) vs. Warfarin in the Treatment of Cerebral venous Sinus Thrombosis (CVST): A retrospective study of functional and radiographic outcomes among patients enrolled in BEAST (Biorepository to Establish the Aetiology of Sinovenous Thrombosis) at UVA. NEUROLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2019.
Published In
NEUROLOGY
EISSN
1526-632X
ISSN
0028-3878
Publication Date
April 9, 2019
Volume
92
Issue
15
Location
Philadelphia, PA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
71st Annual Meeting of the American-Academy-of-Neurology (AAN)
Related Subject Headings
- Neurology & Neurosurgery
- 3209 Neurosciences
- 3202 Clinical sciences
- 1702 Cognitive Sciences
- 1109 Neurosciences
- 1103 Clinical Sciences